Searle & Co. Heron Therapeutics, Inc. Transaction History

Searle & Co.

$396 Million
Q3 2024

A detailed history of Searle & Co. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Searle & Co. holds 86,250 shares of HRTX stock, worth $96,600. This represents 0.04% of its overall portfolio holdings.

Number of Shares

86,250

Previous 11,000 684.09%

Holding current value

$96,600

Previous $38,000 350.0%

% of portfolio

0.04%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$1.73 - $3.67 $130,182 - $276,167	75,250 Added 684.09%	86,250 $171,000
Q2 2024 Jul 30, 2024	SELL	$2.32 - $3.86 $174,580 - $290,465	-75,250 Reduced 87.25%	11,000 $38,000
Q1 2024 May 09, 2024	BUY	$1.71 - $3.06 $1,710 - $3,060	1,000 Added 1.17%	86,250 $238,000
Q3 2023 Nov 03, 2023	BUY	$0.97 - $1.8 $6,790 - $12,600	7,000 Added 8.95%	85,250 $87,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $2.88 $16,650 - $43,200	15,000 Added 23.72%	78,250 $90,000
Q1 2023 Jun 01, 2023	BUY	$1.51 - $3.25 $45,300 - $97,500	30,000 Added 90.23%	63,250 $95,000
Q1 2022 May 10, 2022	SELL	$4.63 - $9.94 $67,135 - $144,130	-14,500 Reduced 30.37%	33,250 $190,000
Q3 2021 Oct 08, 2021	BUY	$10.13 - $15.0 $5,065 - $7,500	500 Added 1.06%	47,750 $510,000
Q2 2021 Jul 29, 2021	BUY	$13.27 - $18.48 $132,700 - $184,800	10,000 Added 26.85%	47,250 $733,000
Q1 2021 May 12, 2021	SELL	$14.49 - $20.72 $7,245 - $10,360	-500 Reduced 1.32%	37,250 $604,000
Q4 2020 Feb 04, 2021	SELL	$14.61 - $22.14 $10,957 - $16,605	-750 Reduced 1.95%	37,750 $799,000
Q3 2020 Oct 30, 2020	BUY	$13.67 - $17.77 $129,865 - $168,815	9,500 Added 32.76%	38,500 $571,000
Q2 2020 Aug 03, 2020	SELL	$10.89 - $21.47 $5,445 - $10,735	-500 Reduced 1.69%	29,000 $427,000
Q1 2020 May 12, 2020	BUY	$10.23 - $24.56 $173,910 - $417,520	17,000 Added 136.0%	29,500 $346,000
Q4 2019 Jan 21, 2020	BUY	$17.42 - $26.61 $26,130 - $39,915	1,500 Added 13.64%	12,500 $294,000
Q3 2019 Oct 22, 2019	SELL	$16.36 - $21.39 $166,054 - $217,108	-10,150 Reduced 47.99%	11,000 $204,000
Q2 2019 Jul 17, 2019	BUY	$16.93 - $26.22 $358,069 - $554,553	21,150 New	21,150 $393,000

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

News

Stay updated on Searle & Co. with notifications on news.

Account